Detalles de la búsqueda
1.
Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study.
Gut
; 64(6): 948-56, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25080450
2.
Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial.
AIDS
; 17(9): 1339-49, 2003 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-12799555
3.
T cells containing T cell receptor excision circles are inversely related to HIV replication and are selectively and rapidly released into circulation with antiretroviral treatment.
AIDS
; 17(8): 1145-9, 2003 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-12819515
4.
Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial.
Lancet Infect Dis
; 12(9): 671-7, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22714001
5.
Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents.
AIDS
; 25(12): 1489-96, 2011 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-21610486
6.
Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE study.
PLoS One
; 5(6): e10952, 2010 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-20532178
7.
Antiviral activity of nucleoside analogues during short-course monotherapy or dual therapy: its role in preventing HIV infection in infants.
J Acquir Immune Defic Syndr
; 42(2): 169-76, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16639342
8.
Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects.
J Acquir Immune Defic Syndr
; 32(1): 18-29, 2003 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12514410
9.
Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia: genetic screening is unnecessary.
J Infect Dis
; 193(11): 1611-2; author reply 1611-2, 2006 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16652295
Resultados
1 -
9
de 9
1
Próxima >
>>